The asthma-rhinitis multimorbidity is associated with IgE polysensitization in adolescents and adults

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 73, Issue 7, 2018, Pages 1447-1458

  Siroux, V ^a   Ballardini, N ^b,c,d   Soler, M ^a   Lupinek, C ^e   Boudier, A ^a   Pin, I ^a,f   Just, J ^g,h   Nadif, R ^h,i   Anto, J M ^j   Melen, E ^b,c   Valenta, R ^e,k   Wickman, M ^b,c,l   Bousquet, J ^h,i  

^a INSTITUTE FOR ADVANCED BIOSCIENCES   (France)

^b KAROLINSKA INSTITUTE   (Sweden)

^c STOCKHOLM SÖDER HOSPITAL   (Sweden)

^d KING'S COLLEGE LONDON   (United Kingdom)

^e MEDICAL UNIVERSITY OF VIENNA   (Austria)

^f GRENOBLE UNIVERSITY HOSPITAL   (France)

^g ARMAND TROUSSEAU HOSPITAL   (France)

^h INSERM   (France)

ⁱ LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^j CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^k INSTITUTE OF IMMUNOLOGY   (Russian Federation)

^l UPPSALA UNIVERSITY   (Sweden)

more..

Author keywords

allergens; epidemiology; multimorbidity; polysensitization; specific IgE

Indexed keywords

IMMUNOGLOBULIN E; IMMUNOSUPPRESSIVE AGENT; ALLERGEN;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPIC DERMATITIS; COHORT ANALYSIS; CONTROLLED STUDY; DESENSITIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CHRONIC CONDITIONS; PHENOTYPE; PRIORITY JOURNAL; SENSITIZATION; SWEDISH CITIZEN; COMORBIDITY; CROSS REACTION; HEALTH SURVEY; IMMUNIZATION; IMMUNOLOGY; MIDDLE AGED; ODDS RATIO; RHINITIS; SWEDEN; YOUNG ADULT;

ADOLESCENT; ADULT; ALLERGENS; ASTHMA; COMORBIDITY; CROSS REACTIONS; FEMALE; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; PUBLIC HEALTH SURVEILLANCE; RHINITIS; SWEDEN; YOUNG ADULT;

EID: 85041622094     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.13410     Document Type: Article

References (33)

1. Zellweger F, Eggel A. IgE-associated allergic disorders: recent advances in etiology, diagnosis, and treatment. Allergy 2016;71:1652-1661.
2. Pinart M, Benet M, Annesi-Maesano I, et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med 2014;2:131-140.
3. Custovic A, Sonntag HJ, Buchan IE, Belgrave D, Simpson A, Prosperi MC. Evolution pathways of IgE responses to grass and mite allergens throughout childhood. J Allergy Clin Immunol 2015;136:1645-1652
4. Bousquet J, Anto JM, Bachert C, et al. Factors responsible for differences between asymptomatic subjects and patients presenting an IgE sensitization to allergens. A GALEN project. Allergy 2006;61:671-680.
5. Bousquet J, Anto JM, Wickman M, et al. Are allergic multimorbidities and IgE polysensitization associated with the persistence or re-occurrence of foetal type 2 signalling? The MeDALL hypothesis Allergy 2015;70:1062-1078.
6. Westman M, Lupinek C, Bousquet J, et al. Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence. J Allergy Clin Immunol 2015;135:1199-1206.
7. Asarnoj A, Hamsten C, Waden K, et al. Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: a BAMSE/MeDALL study. J Allergy Clin Immunol 2016;137:813-821 e817.
8. Gabet S, Just J, Couderc R, Bousquet J, Seta N, Momas I. Early polysensitization is associated with allergic multimorbidity in PARIS birth cohort infants. Pediatr Allergy Immunol 2016;27:831-837.
9. Ballardini N, Bergstrom A, Wahlgren CF, et al. IgE antibodies in relation to prevalence and multimorbidity of eczema, asthma, and rhinitis from birth to adolescence. Allergy 2016;71:342-349.
10. Just J, Saint-Pierre P, Gouvis-Echraghi R, et al. Childhood allergic asthma is not a single phenotype. J Pediatr 2014;164:815-820.
11. Zoratti EM, Krouse RZ, Babineau DC, et al. Asthma phenotypes in inner-city children. J Allergy Clin Immunol 2016;138:1016-1029.
12. Liu AH, Babineau DC, Krouse RZ, et al. Pathways through which asthma risk factors contribute to asthma severity in inner-city children. J Allergy Clin Immunol 2016;138:1042-1050.
13. Pongracic JA, Krouse RZ, Babineau DC, et al. Distinguishing characteristics of difficult-to-control asthma in inner-city children and adolescents. J Allergy Clin Immunol 2016;138:1030-1041.
14. Amat F, Saint-Pierre P, Bourrat E, et al. Early-onset atopic dermatitis in children: which are the phenotypes at risk of asthma? Results from the ORCA cohort. PLoS One 2015;10:e0131369.
15. Just J, Elegbede CF, Deschildre A, et al. Three peanut-allergic/sensitized phenotypes with gender difference. Clin Exp Allergy 2016;46:1596-1604.
16. Burte E, Bousquet J, Siroux V, Just J, Jacquemin B, Nadif R. The sensitization pattern differs according to rhinitis and asthma multimorbidity in adults: the EGEA study. Clin Exp Allergy 2017;47:520-529.
17. Kazemi-Shirazi L, Niederberger V, Linhart B, Lidholm J, Kraft D, Valenta R. Recombinant marker allergens: diagnostic gatekeepers for the treatment of allergy. Int Arch Allergy Immunol 2002;127:259-268.
18. Pfiffner P, Stadler BM, Rasi C, Scala E, Mari A. Cross-reactions vs co-sensitization evaluated by in silico motifs and in vitro IgE microarray testing. Allergy 2012;67:210-216.
19. Hiller R, Laffer S, Harwanegg C, et al. Microarrayed allergen molecules: diagnostic gatekeepers for allergy treatment. FASEB J 2002;16:414-416.
20. Canonica GW, Ansotegui IJ, Pawankar R, et al. A WAO – ARIA – GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J 2013;6:17.
21. Lupinek C, Wollmann E, Baar A, et al. Advances in allergen-microarray technology for diagnosis and monitoring of allergy: the MeDALL allergen-chip. Methods 2014;66:106-119.
22. Skrindo I, Lupinek C, Valenta R, et al. The use of the MeDALL-chip to assess IgE sensitization: a new diagnostic tool for allergic disease? Pediatr Allergy Immunol 2015;26:239-246.
23. Bousquet J, Anto J, Auffray C, et al. MeDALL (Mechanisms of the Development of ALLergy): an integrated approach from phenotypes to systems medicine. Allergy 2011;66:596-604.
24. Kauffmann F, Dizier MH, Annesi-Maesano I, et al. EGEA (Epidemiological study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy)– descriptive characteristics. Clin Exp Allergy 1999;29(Suppl 4):17-21.
25. Wickman M, Kull I, Pershagen G, Nordvall SL. The BAMSE project: presentation of a prospective longitudinal birth cohort study. Pediatr Allergy Immunol 2002;13(Suppl 15):11-13.
26. Kauffmann F, Dizier MH, Pin I, et al. Epidemiological study of the genetics and environment of asthma, bronchial hyperresponsiveness, and atopy: phenotype issues. Am J Respir Crit Care Med 1997;156:S123-S129.
27. Bouzigon E, Corda E, Aschard H, et al. Effect of 17q21 variants and smoking exposure in early-onset asthma. N Engl J Med 2008;359:1985-1994.
28. Siroux V, Lupinek C, Resch Y, et al. Specific IgE and IgG measured by the MeDALL allergen-chip depend on allergen and route of exposure: the EGEA study. J Allergy Clin Immunol 2017;139:643-654.
29. Wickman M, Lupinek C, Andersson N, et al. Detection of IgE reactivity to a handful of allergen molecules in early childhood predicts respiratory allergy in adolescence. EBioMedicine 2017;26:91-99.
30. Bousquet J, Gern JE, Martinez FD, et al. Birth cohorts in asthma and allergic diseases: report of a NIAID/NHLBI/MeDALL joint workshop. J Allergy Clin Immunol 2014;133:1535-1546.
31. Hose AJ, Depner M, Illi S, et al. Latent class analysis reveals clinically relevant atopy phenotypes in 2 birth cohorts. J Allergy Clin Immunol 2017;139:1935-1945.
32. Imhof K, Probst E, Seifert B, Regenass S, Schmid-Grendelmeier P. Ash pollen allergy: reliable detection of sensitization on the basis of IgE to Ole e 1. Allergo J Int 2014;23:78-83.
33. Barderas R, Purohit A, Rodriguez R, Pauli G, Villalba M. Isolation of the main allergen Fra e 1 from ash (Fraxinus excelsior) pollen: comparison of the natural and recombinant forms. Ann Allergy Asthma Immunol 2006;96:557-563.